Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Mesalamine × Clear all

Phase

Phase 2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

Cisplatin 600 Carboplatin 499 Paclitaxel 482 Cyclophosphamide 446 Radiotherapy 442 Docetaxel 407 Fluorouracil 376 Gemcitabine 357 Doxorubicin 338 Capecitabine 308 Dexamethasone 279 Oxaliplatin 242 Vincristine 232 Leucovorin 229 pembrolizumab 228 Etoposide 226 Bevacizumab 225 Rituximab 205 Prednisone 194 Pemetrexed 179 Cytarabine 177 Drug Therapy 169 Methotrexate 147 Trastuzumab 146 Irinotecan 138 Lenalidomide 123 Filgrastim 116 Nivolumab 111 Chemotherapy, Adjuvant 110 Epirubicin 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093663 2021-06-09

PACE

Takeda

Phase 3 Completed

107 enrolled 18 charts

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡